Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Pathogens and Disease|January 23, 2014
The use of Nanotrap particles for biodefense and emerging infectious disease diagnosticsNazly Shafagati, Alexis Patanarut, Alessandra Luchini, et al.
Antiviral Research|February 23, 2023
Venezuelan equine encephalitis virus E1 protein interacts with PDIA6 and PDI inhibition reduces alphavirus productionLauren Panny, Ivan Akrhymuk, Nicole Bracci, et al.
Frontiers in Microbiology|July 29, 2015
Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infectionAshwini Benedict, Neha Bansal, Svetlana Senina, et al.
Viruses|March 30, 2023
Inhibitors of the Ubiquitin-Mediated Signaling Pathway Exhibit Broad-Spectrum Antiviral Activities against New World AlphavirusesNiloufar A Boghdeh, Brittany McGraw, Michael D Barrera, et al.
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|July 15, 2010
microRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infectionLawrence Carpio, Zachary Klase, William Coley, et al.
Lab on a Chip|October 13, 2025
Retraction: Gravity-perfused airway-on-a-chip optimized for quantitative BSL-3 studies of SARS-CoV-2 infection: barrier permeability, cytokine production, immunohistochemistry, and viral load assaysShannon L Faley, Niloufar A Boghdeh, David K Schaffer, et al.
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|October 22, 2010
Erratum to: microRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infectionLawrence Carpio, Zachary Klase, William Coley, et al.
Lab on a Chip|October 14, 2025
Gravity-perfused airway-on-a-chip optimized for quantitative BSL-3 studies of SARS-CoV-2 infection: barrier permeability, cytokine production, immunohistochemistry, and viral load assaysShannon L Faley, Niloufar A Boghdeh, David K Schaffer, et al.
Lab on a Chip|February 16, 2024
Gravity-perfused airway-on-a-chip optimized for quantitative BSL-3 studies of SARS-CoV-2 infection: barrier permeability, cytokine production, immunohistochemistry, and viral load assaysShannon L Faley, Niloufar A Boghdeh, David K Schaffer, et al.
European Journal of Medicinal Chemistry|September 5, 2024
Inhibitor of the non-structural protein 2 protease shows promising efficacy in mouse models of chikungunyaDamilohun S Metibemu, Olawale S Adeyinka, John Falode, et al.
Pageof 12